AbbVie Sues Alvotech Again Alleging At-Risk Adalimumab Launch

Second Lawsuit For Infringement Under BPCIA

 
• By Dean Rudge
  
Risk
Alvotech And AbbVie have exchanged multiple suits • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products